Pura_Diagnostics_Ltd - Accounts


Pura Diagnostics Ltd
Annual Report and Financial Statements
For the year ended 31 December 2020
Company Registration No. 11304862 (England and Wales)
Pura Diagnostics Ltd
Company Information
Directors
J Benton
R Allison
T Woolley
E G Nicholson
E Schmidt-Chiari
Company number
11304862
Registered office
Unit 10 Millars Brook Business Park
Molly Millars Lane
Wokingham
United Kingdom
RG41 2AD
Auditor
Moore Kingston Smith LLP
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Pura Diagnostics Ltd
Directors' Report
For the year ended 31 December 2020
Page 1

The directors present their annual report and financial statements for the year ended 31 December 2020.

Principal activities

The principal activity of the company continued to be that of laboratory testing.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

J Benton
R Allison
T Woolley
E G Nicholson
E Schmidt-Chiari
Auditor

Moore Kingston Smith LLP were appointed as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
J Benton
Director
2 August 2021
Pura Diagnostics Ltd
Directors' Responsibilities Statement
For the year ended 31 December 2020
Page 2

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Pura Diagnostics Ltd
Independent Auditor's Report
To the Member of Pura Diagnostics Ltd
Page 3
Opinion

We have audited the financial statements of Pura Diagnostics Ltd (the 'company') for the year ended 31 December 2020 which comprise the Profit And Loss Account, the Balance Sheet, the Statement of Changes in Equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 31 December 2020 and of its profit for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Pura Diagnostics Ltd
Independent Auditor's Report (Continued)
To the Member of Pura Diagnostics Ltd
Page 4

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the Directors' Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors' Report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of directors' remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit; or

  •     the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the Directors' Report and take advantage of the small companies exemption from the requirement to prepare a Strategic Report.

Responsibilities of directors

As explained more fully in the Directors' Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Pura Diagnostics Ltd
Independent Auditor's Report (Continued)
To the Member of Pura Diagnostics Ltd
Page 5

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the company.

Our approach was as follows:

  • We obtained an understanding of the legal and regulatory requirements applicable to the company and considered that the most significant are the Companies Act 2006, UK financial reporting standards as issued by the Financial Reporting Council, and UK taxation legislation.

  • We obtained an understanding of how the company complies with these requirements by discussions with management and those charged with governance.

  • We assessed the risk of material misstatement of the financial statements, including the risk of material misstatement due to fraud and how it might occur, by holding discussions with management and those charged with governance.

  • We inquired of management and those charged with governance as to any known instances of non-compliance or suspected non-compliance with laws and regulations.

  • Based on this understanding, we designed specific appropriate audit procedures to identify instances of non-compliance with laws and regulations. This included making enquiries of management and those charged with governance and obtaining additional corroborative evidence as required.

 

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

  • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the company’s internal control.

  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.

  • Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.

  • Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

 

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

 

Pura Diagnostics Ltd
Independent Auditor's Report (Continued)
To the Member of Pura Diagnostics Ltd
Page 6
Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken for no purpose other than to draw to the attention of the company’s members those matters we are required to include in an auditor's report addressed to them. To the fullest extent permitted by law, we do not accept or assume responsibility to any party other than the company and the company’s members as a body, for our work, for this report, or for the opinions we have formed.

Karen Wardell (Senior Statutory Auditor)
for and on behalf of Moore Kingston Smith LLP
17 August 2021
Chartered Accountants
Statutory Auditor
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Pura Diagnostics Ltd
Profit and loss account
For the year ended 31 December 2020
Page 7
2020
2019
Notes
£
£
Turnover
2,320,028
383,342
Cost of sales
(1,116,371)
(163,880)
Gross profit
1,203,657
219,462
Administrative expenses
(893,519)
(401,788)
Operating profit/(loss)
310,138
(182,326)
Interest receivable and similar income
6
-
0
Interest payable and similar expenses
(223)
-
0
Profit/(loss) before taxation
309,921
(182,326)
Taxation
3
(49,259)
(17,237)
Profit/(loss) for the financial year
260,662
(199,563)
Pura Diagnostics Ltd
Balance Sheet
As at 31 December 2020
Page 8
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
4
284,017
24,958
Current assets
Debtors
5
409,619
20,651
Cash at bank and in hand
268,567
3,016
678,186
23,667
Creditors: amounts falling due within one year
6
(903,441)
(299,784)
Net current liabilities
(225,255)
(276,117)
Total assets less current liabilities
58,762
(251,159)
Provisions for liabilities
(53,536)
(4,277)
Net assets/(liabilities)
5,226
(255,436)
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
5,126
(255,536)
Total equity
5,226
(255,436)

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 2 August 2021 and are signed on its behalf by:
J Benton
Director
Company Registration No. 11304862
Pura Diagnostics Ltd
Statement of Changes in Equity
For the year ended 31 December 2020
Page 9
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 January 2019
100
(55,973)
(55,873)
Period ended 31 December 2019:
Loss and total comprehensive income for the year
-
(199,563)
(199,563)
Balance at 31 December 2019
100
(255,536)
(255,436)
Year ended 31 December 2020:
Profit and total comprehensive income for the year
-
260,662
260,662
Balance at 31 December 2020
100
5,126
5,226
Pura Diagnostics Ltd
Notes to the Financial Statements
For the year ended 31 December 2020
Page 10
1
Accounting policies
Company information

Pura Diagnostics Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Unit 10 Millars Brook Business Park, Molly Millars Lane, Wokingham, United Kingdom, RG41 2AD.

1.1
Accounting convention

These financial statements have been prepared in accordance with section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The financial statements show the company has net current liabilities of £225,255. Included in creditors is an amount of £388,091 due to a company under the same control, Medical Screening Solutions Limited. The directors have confirmed the connected company will not seek repayment of this balance for a period of at least twelve months from the date of approval of these financial statements if to do so would jeopardise the company's ability to settle its other debts as they fall due. They have also confirmed that they will provide additional financial support to the company during the same period should it be required.

 

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have considered the impact of the COVID-19 outbreak and the measures taken to contain it on the company. In the period following the year end, forecasts were produced and approved by the directors which show the company can continue to operate for at least the next twelve months following the approval of the financial statements. Post year end trading has been reviewed by the directors and the company has grown revenues and continued to produce positive financial results. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Pura Diagnostics Ltd
Notes to the Financial Statements (Continued)
For the year ended 31 December 2020
1
Accounting policies
(Continued)
Page 11

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
33% straight line
Medical equipment
33% straight line
Fixtures and fittings
33% straight line
Computers
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Pura Diagnostics Ltd
Notes to the Financial Statements (Continued)
For the year ended 31 December 2020
1
Accounting policies
(Continued)
Page 12
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

Pura Diagnostics Ltd
Notes to the Financial Statements (Continued)
For the year ended 31 December 2020
1
Accounting policies
(Continued)
Page 13
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 13 (2019 - 7).

3
Taxation
2020
2019
£
£
Deferred tax
Origination and reversal of timing differences
49,259
17,237

The actual charge for the year can be reconciled to the expected charge/(credit) for the year based on the profit or loss and the standard rate of tax as follows:

2020
2019
£
£
Profit/(loss) before taxation
309,921
(182,326)
Expected tax charge/(credit) based on the standard rate of corporation tax in the UK of 19.00% (2019: 19.00%)
58,885
(34,642)
Tax effect of expenses that are not deductible in determining taxable profit
768
70
Tax effect of utilisation of tax losses not previously recognised
(10,432)
-
0
Unutilised tax losses carried forward
-
0
21,567
Group relief
-
0
14,833
Effect of reversal of deferred tax asset on tax losses from the prior year
38
12,960
Effect of assets not qualifying for tax allowances
-
0
2,449
Taxation charge for the year
49,259
17,237
Pura Diagnostics Ltd
Notes to the Financial Statements (Continued)
For the year ended 31 December 2020
Page 14
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2020
-
0
36,501
36,501
Additions
28,776
259,025
287,801
At 31 December 2020
28,776
295,526
324,302
Depreciation and impairment
At 1 January 2020
-
0
11,543
11,543
Depreciation charged in the year
4,641
24,101
28,742
At 31 December 2020
4,641
35,644
40,285
Carrying amount
At 31 December 2020
24,135
259,882
284,017
At 31 December 2019
-
0
24,958
24,958
5
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
328,573
14,467
Other debtors
81,046
6,184
409,619
20,651
6
Creditors: amounts falling due within one year
2020
2019
£
£
Trade creditors
284,289
30,714
Amounts due to group undertakings
369,536
250,499
Other taxation and social security
37,120
7,897
Other creditors
212,496
10,674
903,441
299,784
Pura Diagnostics Ltd
Notes to the Financial Statements (Continued)
For the year ended 31 December 2020
Page 15
7
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2020
2019
Balances:
£
£
Accelerated capital allowances
53,536
4,277
2020
Movements in the year:
£
Liability at 1 January 2020
4,277
Charge to profit or loss
49,259
Liability at 31 December 2020
53,536

The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

8
Called up share capital
2020
2019
£
£
Ordinary share capital
Issued and fully paid
1,000,000 Ordinary shares of 0.01p each
100
100
100
100
9
Financial commitments, guarantees and contingent liabilities

Santander UK PLC holds a fixed and floating charge over the assets of the company, as the Company acts as gurarantor for the bank loan taken out by the parent company, Longacre MSS Group Limited.

 

J Benton holds a fixed and floating charge over the assets of the company, as the Company acts as gurarantor for the Loan Notes taken out by the parent company, Longacre MSS Group Limited.

 

Longacre Group Limited holds a fixed and floating charge over the assets of the company, as the Company acts as gurarantor for the Loan Notes taken out by the parent company, Longacre MSS Group Limited.

Pura Diagnostics Ltd
Notes to the Financial Statements (Continued)
For the year ended 31 December 2020
Page 16
10
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2020
2019
£
£
122,204
32,398
11
Related party transactions

The company is a wholly owned subsidiary of Longacre MSS Group Limited and has taken advantage of the exemption conferred by FRS 102 not to disclose transactions with Longacre MSS Group Limited or other wholly owned subsidiaries within the group.

12
Parent company

The company is a wholly owned subsidiary of Longacre MSS Group Limited, a company incorporated in England and Wales.

 

Longacre Group Limited is the smallest and largest group to prepare consolidated financial statements which include these financial statements. Copies of the financial statements can be obtained from 1 Mercer Street, London, WC2H 9QJ.

 

The directors consider I Abrahams to be the ultimate controlling party.

2020-12-312020-01-01falseCCH SoftwareCCH Accounts Production 2021.100J BentonR AllisonT WoolleyT WoolleyE G Nicholson113048622020-01-012020-12-3111304862bus:Director12020-01-012020-12-3111304862bus:Director22020-01-012020-12-3111304862bus:Director42020-01-012020-12-3111304862bus:Director52020-01-012020-12-3111304862bus:Director62020-01-012020-12-3111304862bus:Director32020-01-012020-12-3111304862bus:RegisteredOffice2020-01-012020-12-31113048622020-12-31113048622019-01-012019-12-31113048622019-12-3111304862core:LandBuildings2020-12-3111304862core:OtherPropertyPlantEquipment2020-12-3111304862core:LandBuildings2019-12-3111304862core:OtherPropertyPlantEquipment2019-12-3111304862core:CurrentFinancialInstruments2020-12-3111304862core:CurrentFinancialInstruments2019-12-3111304862core:ShareCapital2020-12-3111304862core:ShareCapital2019-12-3111304862core:RetainedEarningsAccumulatedLosses2020-12-3111304862core:RetainedEarningsAccumulatedLosses2019-12-3111304862core:ShareCapitalcore:RestatedAmount2018-12-3111304862core:RetainedEarningsAccumulatedLossescore:RestatedAmount2018-12-3111304862core:RestatedAmount2018-12-3111304862core:ShareCapitalOrdinaryShares2020-12-3111304862core:ShareCapitalOrdinaryShares2019-12-3111304862core:LeaseholdImprovementscore:LeasedAssetsHeldAsLessee2020-01-012020-12-3111304862core:PlantMachinery2020-01-012020-12-3111304862core:FurnitureFittings2020-01-012020-12-3111304862core:ComputerEquipment2020-01-012020-12-3111304862core:UKTax2020-01-012020-12-3111304862core:UKTax2019-01-012019-12-311130486212020-01-012020-12-311130486212019-01-012019-12-311130486222020-01-012020-12-311130486222019-01-012019-12-3111304862core:LandBuildings2019-12-3111304862core:OtherPropertyPlantEquipment2019-12-31113048622019-12-3111304862core:LandBuildings2020-01-012020-12-3111304862core:OtherPropertyPlantEquipment2020-01-012020-12-3111304862bus:OrdinaryShareClass12020-01-012020-12-3111304862bus:OrdinaryShareClass12020-12-3111304862bus:PrivateLimitedCompanyLtd2020-01-012020-12-3111304862bus:FRS1022020-01-012020-12-3111304862bus:Audited2020-01-012020-12-3111304862bus:FullAccounts2020-01-012020-12-31xbrli:purexbrli:sharesiso4217:GBP